{"id":815300,"date":"2025-02-20T05:48:39","date_gmt":"2025-02-20T10:48:39","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\/"},"modified":"2025-02-20T05:48:39","modified_gmt":"2025-02-20T10:48:39","slug":"astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\/","title":{"rendered":"AstraZeneca PLC Class Action: The Gross Law Firm Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 &#8211; AZN"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">NEW YORK<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Feb. 20, 2025<\/span><\/span> \/PRNewswire\/ &#8212; The Gross Law Firm issues the following notice to shareholders of <b>AstraZeneca PLC (NASDAQ: AZN).<\/b><\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg\" title=\"The Gross Law Firm (PRNewsfoto\/The Gross Law Firm)\" alt=\"The Gross Law Firm (PRNewsfoto\/The Gross Law Firm)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>Shareholders who purchased shares of AZN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.<\/p>\n<p class=\"prntac\">CONTACT US HERE:<\/p>\n<p class=\"prntac\">\n        <a href=\"https:\/\/securitiesclasslaw.com\/securities\/astrazeneca-plc-loss-submission-form-2\/?id=130514&amp;from=4\" rel=\"nofollow\">https:\/\/securitiesclasslaw.com\/securities\/astrazeneca-plc-loss-submission-form-2\/?id=130514&amp;from=4<\/a>\n      <\/p>\n<p>\n        <b>CLASS PERIOD: <\/b><br \/>\n        <span class=\"xn-chron\">February 23, 2022<\/span> to <span class=\"xn-chron\">December 17, 2024<\/span><\/p>\n<p>\n        <b>ALLEGATIONS: <\/b>The complaint <span>alleges<\/span> that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (1) AstraZeneca engaged in insurance <span>fraud<\/span> in <span class=\"xn-location\">China<\/span>; (2) as a result, AstraZeneca faced heightened legal exposure in <span class=\"xn-location\">China<\/span>, which eventually resulted in the AstraZeneca China President being detained by Chinese law enforcement authorities; (3) as a result, AstraZeneca understated its legal risks; (4) the foregoing, once revealed, could materially harm AstraZeneca&#8217;s business activities in <span class=\"xn-location\">China<\/span>; and (5) as a result, defendants&#8217; statements about its business, operations, and prospects, were materially false and misleading and\/or lacked a reasonable basis at all relevant times.<\/p>\n<p>\n        <b>DEADLINE: <span class=\"xn-chron\">February 21, 2025<\/span><\/b> Shareholders should not delay in registering for this class action. Register your information here: <a href=\"https:\/\/securitiesclasslaw.com\/securities\/astrazeneca-plc-loss-submission-form-2\/?id=130514&amp;from=4\" rel=\"nofollow\">https:\/\/securitiesclasslaw.com\/securities\/astrazeneca-plc-loss-submission-form-2\/?id=130514&amp;from=4<\/a><\/p>\n<p>\n        <b>NEXT STEPS FOR SHAREHOLDERS: <\/b>Once you register as a shareholder who purchased shares of AZN during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is <span class=\"xn-chron\">February 21, 2025<\/span>. There is no cost or obligation to you to participate in this case.<\/p>\n<p>\n        <b>WHY GROSS LAW FIRM? <\/b>The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, <span>fraud<\/span>, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and\/or misleading statements or the omission of material information by a company lead to artificial inflation of the company&#8217;s stock. Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>\n        <b>CONTACT:<\/b><br \/>\n        <br \/>The Gross Law Firm<br \/>15 West 38th Street, 12th floor<br \/><span class=\"xn-location\">New York, NY<\/span>, 10018<br \/>Email: <a href=\"mailto:dg@securitiesclasslaw.com\" rel=\"nofollow\">dg@securitiesclasslaw.com<\/a><br \/>Phone: (646) 453-8903<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY22937&amp;sd=2025-02-20\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025--azn-302380587.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025&#8211;azn-302380587.html<\/a><\/p>\n<p>SOURCE  The Gross Law Firm<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY22937&amp;Transmission_Id=202502200545PR_NEWS_USPR_____NY22937&amp;DateId=20250220\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK , Feb. 20, 2025 \/PRNewswire\/ &#8212; The Gross Law Firm issues the following notice to shareholders of AstraZeneca PLC (NASDAQ: AZN). Shareholders who purchased shares of AZN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/astrazeneca-plc-loss-submission-form-2\/?id=130514&amp;from=4 CLASS PERIOD: February 23, 2022 to December 17, 2024 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (1) AstraZeneca engaged in insurance fraud in China; (2) as a result, AstraZeneca faced heightened legal exposure in China, which eventually resulted in the AstraZeneca China President &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;AstraZeneca PLC Class Action: The Gross Law Firm Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 &#8211; AZN&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-815300","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AstraZeneca PLC Class Action: The Gross Law Firm Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 - AZN - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AstraZeneca PLC Class Action: The Gross Law Firm Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 - AZN - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK , Feb. 20, 2025 \/PRNewswire\/ &#8212; The Gross Law Firm issues the following notice to shareholders of AstraZeneca PLC (NASDAQ: AZN). Shareholders who purchased shares of AZN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/astrazeneca-plc-loss-submission-form-2\/?id=130514&amp;from=4 CLASS PERIOD: February 23, 2022 to December 17, 2024 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (1) AstraZeneca engaged in insurance fraud in China; (2) as a result, AstraZeneca faced heightened legal exposure in China, which eventually resulted in the AstraZeneca China President &hellip; Continue reading &quot;AstraZeneca PLC Class Action: The Gross Law Firm Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 &#8211; AZN&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-20T10:48:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"AstraZeneca PLC Class Action: The Gross Law Firm Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 &#8211; AZN\",\"datePublished\":\"2025-02-20T10:48:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\\\/\"},\"wordCount\":432,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280333\\\/The_Gross_Law_Firm_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\\\/\",\"name\":\"AstraZeneca PLC Class Action: The Gross Law Firm Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 - AZN - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280333\\\/The_Gross_Law_Firm_Logo.jpg\",\"datePublished\":\"2025-02-20T10:48:39+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280333\\\/The_Gross_Law_Firm_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280333\\\/The_Gross_Law_Firm_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AstraZeneca PLC Class Action: The Gross Law Firm Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 &#8211; AZN\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AstraZeneca PLC Class Action: The Gross Law Firm Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 - AZN - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\/","og_locale":"en_US","og_type":"article","og_title":"AstraZeneca PLC Class Action: The Gross Law Firm Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 - AZN - Market Newsdesk","og_description":"PR Newswire NEW YORK , Feb. 20, 2025 \/PRNewswire\/ &#8212; The Gross Law Firm issues the following notice to shareholders of AstraZeneca PLC (NASDAQ: AZN). Shareholders who purchased shares of AZN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/astrazeneca-plc-loss-submission-form-2\/?id=130514&amp;from=4 CLASS PERIOD: February 23, 2022 to December 17, 2024 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (1) AstraZeneca engaged in insurance fraud in China; (2) as a result, AstraZeneca faced heightened legal exposure in China, which eventually resulted in the AstraZeneca China President &hellip; Continue reading \"AstraZeneca PLC Class Action: The Gross Law Firm Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 &#8211; AZN\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-20T10:48:39+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"AstraZeneca PLC Class Action: The Gross Law Firm Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 &#8211; AZN","datePublished":"2025-02-20T10:48:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\/"},"wordCount":432,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\/","name":"AstraZeneca PLC Class Action: The Gross Law Firm Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 - AZN - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg","datePublished":"2025-02-20T10:48:39+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-class-action-the-gross-law-firm-reminds-astrazeneca-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-february-21-2025-azn-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"AstraZeneca PLC Class Action: The Gross Law Firm Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 &#8211; AZN"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815300","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=815300"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815300\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=815300"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=815300"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=815300"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}